Skip to main content

Actors and Network database

The evolving field of gene and cell therapy is supported by a large community of academic, clinical, translational, regulatory and patient organisations. The Actors and Networks database maps these stakeholders in Europe and beyond, their activities, and resources they have produced. 

EuroGCT has developed and compiled this database for those interested in identifying the actors involved at each stage of the pathways bringing gene and cell therapies from lab to clinic. Coming from an academic perspective, our focus is to map information that has not been mapped elsewhere. This includes documenting the various types of interconnected regulators, patient groups actively involved along the pathways, and non-profit organisations devoted to therapy development. In its first iteration, this database does not yet include commercial partners and service providers.

Showing 10 of 33

Alliance for Regenerative Medicine (ARM)

Region/Country:  
  • Global

Type of Actor:

  • Networks
  • Other International Networks

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Translational Research
  • Manufacturing
  • Commercialisation

Additional information

ARM is an international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies. ARM represents the interests of 400+ members across 25 countries, including small and large companies, academic research institutions, major medical centers and patient groups.

ATMP Sweden

Region/Country:  
  • Countries in the EU/EEA
  • Sweden

Type of Actor:

  • Networks
  • European and Regional Networks

Development Stage:

  • Clinical Research
  • Translational Research
  • Manufacturing
  • Commercialisation

Additional information

ATMP Sweden is a national network for activities on Advanced Therapy Medicinal Products (ATMPs)

Austrian Federal Office for Safety in Health Care (BASG)

Region/Country:  
  • Countries in the EU/EEA
  • Austria

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for Tissues and Cells
  • Competent Authorities for Blood and Blood Components

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

Additional information

BASG work as the national authority for medicines, medical devices, blood and tissue together with the Austrian Medicines and Medical Devices Agency, a business division of the Austrian Agency for Health and FoodSafety (AGES MEA).

Bulgarian Drug Agency (BDA)

Region/Country:  
  • Countries in the EU/EEA
  • Bulgaria

Type of Actor:

  • Regulators
  • Medicines Agencies
  • National Medicines Agencies
  • Other National competent authorities
  • Competent Authorities for Blood and Blood Components

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

Additional information

The BDA is the national medicines agency and the competent authority for blood and blood components in Bulgaria

Bulgarian Executive Agency for Transplantation (BEAT)

Region/Country:  
  • Countries in the EU/EEA
  • Bulgaria
Website:  

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for Tissues and Cells

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

Additional information

The Bulgarian Executive Agency for Transplantation (BEAT) is the competent authority for management, coordination and control of transplantation of organs, tissues and cells in Bulgaria

Caring Cross

Region/Country:  
  • USA

Type of Actor:

  • Networks
  • Other International Networks

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation
  • Patient and Public Involvement

Additional information

Caring Cross aims to accelerate the development of advanced medicines and ensure access for ALL patients by organizing and supporting a community of healthcare professionals, scientists and engineers, community advocates and business leaders.

Resources

Centre d'Etudes et de Recherches Internationales et Communautaires (CERIC)

Region/Country:  
  • Countries in the EU/EEA
  • France

Type of Actor:

  • Non-profit Research Organisations
  • Academic Bodies

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Translational Research
  • Manufacturing
  • Commercialisation

Additional information

CERIC is a multidisciplinary research team comprising mainly lawyers in public and private law, specialists in domestic, comparative, international and European law

Resources

The ELSIBI notebook aims to spread researches in law at the crossroad with other scientific disciplines in the field of Ethical, Legal and Social Implications of Biomedical Innovations for the scientific community at large: https://elsibi.hypotheses.org/about

Centre for Regenerative Medicine, University of Edinburgh (CRM)

Region/Country:  
  • UK

Type of Actor:

  • Non-profit Research Organisations
  • Academic Bodies

Development Stage:

  • Fundamental Research
  • Clinical Research

Conditions and Diseases:

  • Heart disease
  • Cancer
  • Parkinson's Disease
  • Multiple Sclerosis

Additional information

The Centre for Regenerative Medicine (CRM) is a research centre based at the University of Edinburgh's Institute for Regeneration and Repair. Our Scientists and clinicians study stem cells, disease and tissue repair to advance human health. Research at the Centre is aimed at developing new treatments for major diseases including cancer, heart disease, liver failure, and degenerative diseases such as multiple sclerosis and Parkinson's.

Croatian Agency for Medicinal Products and Medical Devices (HALMED)

Region/Country:  
  • Countries in the EU/EEA
  • Croatia

Type of Actor:

  • Regulators
  • Medicines Agencies
  • National Medicines Agencies

Development Stage:

  • Manufacturing
  • Commercialisation

Additional information

The Croatian Agency for Medicinal Products and Medical Devices (HALMED) engages in regulatory affairs related to medicinal products and medical devices and conducts all activities and procedures involving the evaluation of their quality, efficiency and safety. Further information regarding HALMED's activities can be found at: https://www.halmed.hr/en/O-HALMED-u/Osnovni-podaci-i-dokumenti/Djelatnosti/

Resources

HALMED's medicinal products database: https://www.halmed.hr/en/Lijekovi/Baza-lijekova/

Cyprus Ministry of Health

Region/Country:  
  • Countries in the EU/EEA
  • Cyprus

Type of Actor:

  • Regulators
  • Medicines Agencies
  • National Medicines Agencies
  • Other National competent authorities
  • Competent Authorities for Tissues and Cells
  • Competent Authorities for Blood and Blood Components

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

Additional information

The Cyprus Ministry of Health is the national medicines agency, the competent authority for blood and blood components, and for tissues and cells in Cyprus.

Resources

The Cyprus Ministry of Health's pharmaceutical services: https://www.moh.gov.cy/moh/phs/phs.nsf/home_en/home_en?openform
¿Le pareció útil el contenido de esta página? Envianos tus comentarios